Summary
15.09 -0.26(-1.69%)09/06/2024
Elanco Animal Health Inc (ELAN)
Elanco Animal Health Inc (ELAN)
Key Facts
1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
-1.76 | -2.42 | 20.53 | -17.36 | -5.98 | 26.07 | -44.83 | -58.08 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
Trading Data | ||
Close | 15.09 | |
Open | 15.34 | |
High | 15.57 | |
Low | 15.09 | |
Volume | 3,156,271 | |
Change | -0.27 | |
Change % | -1.76 | |
Avg Volume (20 Days) | 3,035,001 | |
Volume/Avg Volume (20 Days) Ratio | 1.04 | |
52 Week Range | 8.52 - 18.77 | |
Price vs 52 Week High | -19.61% | |
Price vs 52 Week Low | 77.11% | |
Range | -1.63 | |
Gap Up/Down | -0.14 |
Fundamentals | ||
Market Capitalization (Mln) | 7,459 | |
EBIDTA | 1,025,200,000 | |
PE Ratio | 0.0000 | |
PEG Ratio | 1.8448 | |
WallStreet Target Price | 35.00 | |
Book Value | 16.2400 | |
Earnings Per Share | -1.4340 | |
EPS Estimate Current Quarter | 0.1600 | |
EPS Estimate Next Quarter | 0.1900 | |
EPS Estimate Current Year | 1.0200 | |
EPS Estimate Next Year | 1.2300 | |
Diluted EPS (TTM) | -1.4340 | |
Revenues | ||
Profit Marging | -0.1457 | |
Operating Marging (TTM) | 0.0618 | |
Return on asset (TTM) | 0.0110 | |
Return on equity (TTM) | -0.0871 | |
Revenue TTM | 4,791,300,096 | |
Revenue per share TTM | 9.8410 | |
Quarterly Revenue Growth (YOY) | 0.2710 | |
Quarterly Earnings Growth (YOY) | -0.8650 | |
Gross Profit (TTM) | 1,696,800,000 |
Dividends | ||
Dividend Share | 0.0000 | |
Dividend Yield | ||
Valuations | ||
Trailing PE | 0.0000 | |
Forward PE | 22.3714 | |
Price Sales (TTM) | 0.0000 | |
Price Book (MRQ) | 1.7225 | |
Revenue Enterprise Value | 3.9892 | |
EBITDA Enterprise Value | 79.0797 | |
Shares | ||
Shares Outstanding | 473,099,008 | |
Shares Float | 425,590,077 | |
Shares Short | 0 | |
Shares Short (Prior Month) | 0 | |
Shares Ratio | 0.00 | |
Short Outstanding (%) | 0.00 | |
Short Float (%) | 0.00 | |
Insider (%) | 4.23 | |
Institutions (%) | 103.47 |
09/06 11:00 EST - accesswire.com
The Schall Law Firm Is Looking Into Whether Elanco Animal Health Incorporated Violated Securities Regulations And Investors Are Urged To Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Is Looking Into Whether Elanco Animal Health Incorporated Violated Securities Regulations And Investors Are Urged To Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/05 11:00 EST - accesswire.com
Elanco Animal Health Incorporated May Have Engaged In Fraudulent Activities And The Schall Law Firm Seeks Shareholder Participation In An Investigation
LOS ANGELES, CA / ACCESSWIRE / September 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Elanco Animal Health Incorporated May Have Engaged In Fraudulent Activities And The Schall Law Firm Seeks Shareholder Participation In An Investigation
LOS ANGELES, CA / ACCESSWIRE / September 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/04 11:00 EST - accesswire.com
Investors Are Invited To Join The Schall Law Firm In A Securities Fraud Inquiry Into Elanco Animal Health Incorporated
LOS ANGELES, CA / ACCESSWIRE / September 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Investors Are Invited To Join The Schall Law Firm In A Securities Fraud Inquiry Into Elanco Animal Health Incorporated
LOS ANGELES, CA / ACCESSWIRE / September 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/03 11:00 EST - accesswire.com
The Schall Law Firm Is Looking Into Whether Elanco Animal Health Incorporated Defrauded Shareholders And The Public Is Urged To Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Is Looking Into Whether Elanco Animal Health Incorporated Defrauded Shareholders And The Public Is Urged To Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/02 11:00 EST - accesswire.com
Investors In Elanco Animal Health Incorporated Are Invited By The Schall Law Firm To Help With An Investigation Into Securities Law Infractions
LOS ANGELES, CA / ACCESSWIRE / September 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Investors In Elanco Animal Health Incorporated Are Invited By The Schall Law Firm To Help With An Investigation Into Securities Law Infractions
LOS ANGELES, CA / ACCESSWIRE / September 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/01 11:00 EST - accesswire.com
The Schall Law Firm Is Opening An Inquiry Into Whether Elanco Animal Health Incorporated Committed Securities Fraud And Stockholders Should Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Is Opening An Inquiry Into Whether Elanco Animal Health Incorporated Committed Securities Fraud And Stockholders Should Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
08/31 11:00 EST - accesswire.com
Elanco Animal Health Incorporated Is Being Looked Into For Possibly Violating Securities Laws And The Schall Law Firm Is Inviting Investors To Play A Part
LOS ANGELES, CA / ACCESSWIRE / August 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Elanco Animal Health Incorporated Is Being Looked Into For Possibly Violating Securities Laws And The Schall Law Firm Is Inviting Investors To Play A Part
LOS ANGELES, CA / ACCESSWIRE / August 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
08/30 11:00 EST - accesswire.com
The Schall Law Firm Seeks The Public's Assistance In A Securities Fraud Investigation Into Elanco Animal Health Incorporated
LOS ANGELES, CA / ACCESSWIRE / August 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Seeks The Public's Assistance In A Securities Fraud Investigation Into Elanco Animal Health Incorporated
LOS ANGELES, CA / ACCESSWIRE / August 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
08/29 11:00 EST - accesswire.com
Shareholders In Elanco Animal Health Incorporated Are Encouraged To Help The Schall Law Firm With An Inquiry Into Whether Securities Laws Were Violated
LOS ANGELES, CA / ACCESSWIRE / August 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Shareholders In Elanco Animal Health Incorporated Are Encouraged To Help The Schall Law Firm With An Inquiry Into Whether Securities Laws Were Violated
LOS ANGELES, CA / ACCESSWIRE / August 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
08/28 11:30 EST - accesswire.com
Levi & Korsinsky Reminds Elanco Investors of the Ongoing Investigation into Potential Violations of Securities Laws - ELAN
NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Elanco Animal Health Incorporated ("Elanco") (NYSE:ELAN) concerning possible violations of federal securities laws. Elanco issued a press release on June 27, 2024, "announc[ing] updates to the expected U.S. Food and Drug Administration (FDA) approval timelines for Zenrelia and Credelio Quattro.
Levi & Korsinsky Reminds Elanco Investors of the Ongoing Investigation into Potential Violations of Securities Laws - ELAN
NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Elanco Animal Health Incorporated ("Elanco") (NYSE:ELAN) concerning possible violations of federal securities laws. Elanco issued a press release on June 27, 2024, "announc[ing] updates to the expected U.S. Food and Drug Administration (FDA) approval timelines for Zenrelia and Credelio Quattro.
08/28 11:00 EST - accesswire.com
Elanco Animal Health Incorporated May Have Committed Securities Fraud And The Schall Law Firm Is Seeking Investors To Join An Investigation
LOS ANGELES, CA / ACCESSWIRE / August 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Elanco Animal Health Incorporated May Have Committed Securities Fraud And The Schall Law Firm Is Seeking Investors To Join An Investigation
LOS ANGELES, CA / ACCESSWIRE / August 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
08/28 06:30 EST - prnewswire.com
Elanco to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference
GREENFIELD, Ind. , Aug. 28, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Morgan Stanley 22nd Annual Global Healthcare Conference, September 4-5, 2024.
Elanco to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference
GREENFIELD, Ind. , Aug. 28, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Morgan Stanley 22nd Annual Global Healthcare Conference, September 4-5, 2024.
08/27 11:30 EST - accesswire.com
Elanco Animal Health Incorporated Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - ELAN
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Elanco Animal Health Incorporated ("Elanco") (NYSE:ELAN) concerning possible violations of federal securities laws. Elanco issued a press release on June 27, 2024, "announc[ing] updates to the expected U.S. Food and Drug Administration (FDA) approval timelines for Zenrelia and Credelio Quattro.
Elanco Animal Health Incorporated Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - ELAN
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Elanco Animal Health Incorporated ("Elanco") (NYSE:ELAN) concerning possible violations of federal securities laws. Elanco issued a press release on June 27, 2024, "announc[ing] updates to the expected U.S. Food and Drug Administration (FDA) approval timelines for Zenrelia and Credelio Quattro.
08/27 11:00 EST - accesswire.com
The Schall Law Firm Wants Shareholders To Reach Out About Elanco Animal Health's Potential Securities Law Violations
LOS ANGELES, CA / ACCESSWIRE / August 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Wants Shareholders To Reach Out About Elanco Animal Health's Potential Securities Law Violations
LOS ANGELES, CA / ACCESSWIRE / August 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
08/27 07:25 EST - accesswire.com
Elanco Animal Health Incorporated Investigated by Shareholder Rights Advocates – Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - ELAN
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Elanco Animal Health Incorporated ("Elanco") (NYSE:ELAN) concerning possible violations of federal securities laws. Elanco issued a press release on June 27, 2024, "announc[ing] updates to the expected U.S. Food and Drug Administration (FDA) approval timelines for Zenrelia and Credelio Quattro.
Elanco Animal Health Incorporated Investigated by Shareholder Rights Advocates – Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - ELAN
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Elanco Animal Health Incorporated ("Elanco") (NYSE:ELAN) concerning possible violations of federal securities laws. Elanco issued a press release on June 27, 2024, "announc[ing] updates to the expected U.S. Food and Drug Administration (FDA) approval timelines for Zenrelia and Credelio Quattro.
08/26 11:00 EST - accesswire.com
Elanco Animal Health Incorporated Is Being Investigated For Possible Securities Fraud And Investors Are Invited To Play A Part
LOS ANGELES, CA / ACCESSWIRE / August 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Elanco Animal Health Incorporated Is Being Investigated For Possible Securities Fraud And Investors Are Invited To Play A Part
LOS ANGELES, CA / ACCESSWIRE / August 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
08/25 12:17 EST - accesswire.com
Investors who lost money on Elanco Animal Health Incorporated should contact Levi & Korsinsky about an ongoing investigation - ELAN
NEW YORK, NY / ACCESSWIRE / August 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Elanco Animal Health Incorporated ("Elanco") (NYSE:ELAN) concerning possible violations of federal securities laws. Elanco issued a press release on June 27, 2024, "announc[ing] updates to the expected U.S. Food and Drug Administration (FDA) approval timelines for Zenrelia and Credelio Quattro.
Investors who lost money on Elanco Animal Health Incorporated should contact Levi & Korsinsky about an ongoing investigation - ELAN
NEW YORK, NY / ACCESSWIRE / August 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Elanco Animal Health Incorporated ("Elanco") (NYSE:ELAN) concerning possible violations of federal securities laws. Elanco issued a press release on June 27, 2024, "announc[ing] updates to the expected U.S. Food and Drug Administration (FDA) approval timelines for Zenrelia and Credelio Quattro.
08/25 11:00 EST - accesswire.com
An Inquiry Has Been Launched Into Elanco Animal Health Incorporated For Securities Law Violations And The Schall Law Firm Is Seeking Shareholder Participation
LOS ANGELES, CA / ACCESSWIRE / August 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
An Inquiry Has Been Launched Into Elanco Animal Health Incorporated For Securities Law Violations And The Schall Law Firm Is Seeking Shareholder Participation
LOS ANGELES, CA / ACCESSWIRE / August 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
08/24 21:01 EST - accesswire.com
ELAN ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Elanco Animal Health Incorporated investment
NEW YORK, NY / ACCESSWIRE / August 24, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Elanco Animal Health Incorporated ("Elanco") (NYSE:ELAN) concerning possible violations of federal securities laws. Elanco issued a press release on June 27, 2024, "announc[ing] updates to the expected U.S. Food and Drug Administration (FDA) approval timelines for Zenrelia and Credelio Quattro.
ELAN ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Elanco Animal Health Incorporated investment
NEW YORK, NY / ACCESSWIRE / August 24, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Elanco Animal Health Incorporated ("Elanco") (NYSE:ELAN) concerning possible violations of federal securities laws. Elanco issued a press release on June 27, 2024, "announc[ing] updates to the expected U.S. Food and Drug Administration (FDA) approval timelines for Zenrelia and Credelio Quattro.
08/24 11:00 EST - accesswire.com
The Schall Law Firm Is Looking Into Elanco Animal Health Incorporated For Potential Securities Fraud And Investors Are Encouraged To Join
LOS ANGELES, CA / ACCESSWIRE / August 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Is Looking Into Elanco Animal Health Incorporated For Potential Securities Fraud And Investors Are Encouraged To Join
LOS ANGELES, CA / ACCESSWIRE / August 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.